683 Capital Management »

Actinium Pharmaceuticals shares owned by 683 Capital Management

Quarter-by-quarter ownership of Actinium Pharmaceuticals (ATNM) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Actinium Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Actinium Pharmaceuticals held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actinium Pharmaceuticals by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $151k 16k 9.45
2022-12-31 $177k 17k 10.65

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Madrigal Pharmaceuticals Put Option (MDGL)
Uniqure Nv SHS (QURE)
Alnylam Pharmaceuticals Put Option (ALNY)
Carvana Cl A (CVNA)
Insmed Com Par $.01 Put Option (INSM)
Uwm Holdings Corporation Com Cl A (UWMC)
Strategy Cl A New Put Option (MSTR)
Gxo Logistics Incorporated Common Stock (GXO)
Western Digital (WDC)
Novo-nordisk A S Adr Put Option (NVO)
United Therapeutics Corporation Put Option (UTHR)

View all positions for 683 Capital Management

Top funds holding Actinium Pharmaceuticals

Vanguard Group
Millennium Management
Acadian Asset Management
BlackRock
Geode Capital Management
Renaissance Technologies
Two Sigma Investments
Gagnon Securities
Two Sigma Advisers
Citadel Advisors
State Street Corporation
Susquehanna International
Gen-Wealth Partners
Jane Street
Bridgeway Capital Management

View all funds holding Actinium Pharmaceuticals